To include your compound in the COVID-19 Resource Center, submit it here.
BerGenBio ASA (OSE:BGBIO) said Clinical Development Officer Murray Yule will step down on Nov. 30. The cancer company hired
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury